Novavax

Yahoo Finance • 9 hours ago

Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Pfizer agreement announced in January 2026 for non-exclusive license to utilize Matrix-M® in two infectious disease areas Multiple Material Transfer Agreements signed in 2025 and Q1 2026 with pharmaceutical companies, including major globa... Full story

Yahoo Finance • 24 days ago

Pfizer Taps Novavax Matrix-M To Refresh Vaccine Growth Story

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Pfizer, NYSE:PFE, has entered a global licensing agreement with Novavax to use Matrix-M adjuvant t... Full story

Yahoo Finance • 3 months ago

Moderna Slammed By 'Fear, Confusion' After FDA Alleges Covid Shots Killed 10

Moderna and other vaccine stocks tumbled Monday after an FDA director reportedly issued a memo that says Covid shots killed 10 children. Continue Reading View Comments... Full story

Yahoo Finance • 3 months ago

Nvidia's Synopsys investment, Disney stock pops on Zootopia 2

Yahoo Finance host Julie Hyman kicks off Yahoo Finance's Market Minute with some of the top stories of Monday's trading session, including Nvidia's (NVDA) investment in Synopsys (SNPS), Disney's (DIS) "Zootopia 2," and vaccine stock moves.... Full story

Yahoo Finance • 3 months ago

Shares of vaccine makers drop after FDA memo flags reports of child deaths

Investing.com -- Shares in major COVID-19 vaccine makers fell on Monday after an internal U.S. Food and Drug Administration (FDA) memo reportedly suggested that vaccinations may have contributed to several child deaths linked to heart infl... Full story

Yahoo Finance • 3 months ago

FDA official Prasad says COVID shot deaths mean stricter vaccine approval standards

[Doctor Vaccinating Little Girl Close Up] SeventyFour/iStock via Getty Images Vinay Prasad, the head of the US FDA's Center for Biologics Evaluations and Research which oversees vaccines, said that future vaccine approvals will face stric... Full story

Yahoo Finance • 3 months ago

January 2026 Options Now Available For Novavax (NVAX)

Investors in Novavax, Inc. (Symbol: NVAX) saw new options become available today, for the January 2026 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the NVAX options chain for the new January 2026 co... Full story

Yahoo Finance • 3 months ago

Vaccine critic selected as CDC deputy director

[CDC Headquarters] hapabapa Ralph Abraham, Louisiana's surgeon general, is the CDC's next deputy director. _The Washington Post_, which broke [https://www.washingtonpost.com/health/2025/11/25/cdc-new-deputy-vaccine-ralph-abraham/] the de... Full story

Yahoo Finance • 3 months ago

Novavax Shifts From COVID Sales to R&D Focus While Updating 2025 Forecast

Novavax, Inc. (NASDAQ:NVAX) ranks among the most oversold biotech stocks to invest in. Novavax, Inc. (NASDAQ:NVAX) announced its third-quarter 2025 financial results on November 6, emphasizing the company’s continuous strategic shift from... Full story

Yahoo Finance • 3 months ago

Novavax rises after a seven-day slide

Novavax (NVAX [https://seekingalpha.com/symbol/NVAX]) rose 3.70% to close at $6.45 on Friday, snapping a seven-session losing streak, with notable drops of 3.38% and 3.50% on November 18 and 19. Novavax now expects to reach profitability... Full story

Yahoo Finance • 4 months ago

Novavax outlines $1.04B–$1.06B 2025 revenue framework and targets non-GAAP profitability as early as 2028 amid partnership-driven transition

Earnings Call Insights: Novavax (NVAX) Q3 2025 MANAGEMENT VIEW * John Jacobs, President, CEO & Director, stated that Novavax has made significant progress in Q3 by strengthening existing partnerships and building new collaborations whi... Full story

Yahoo Finance • 4 months ago

NVAX December 26th Options Begin Trading

Investors in Novavax, Inc. (Symbol: NVAX) saw new options begin trading today, for the December 26th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the NVAX options chain for the new December 26th con... Full story

Yahoo Finance • 4 months ago

Novavax raises annual revenue forecast on strength of vaccine deals

(Reuters) -Novavax raised its annual revenue forecast for the third time this year on Thursday, banking on milestone payments from vaccine supply and licensing deals such as with Japan's Takeda Pharmaceuticals. The upbeat outlook comes as... Full story

Yahoo Finance • 4 months ago

Novavax (NVAX) Gains Momentum with Sanofi Deal and Analyst Endorsement

Novavax, Inc. (NASDAQ:NVAX) is one of the top long-term biotechnology stocks to buy. On October 24, Cantor Fitzgerald initiated coverage of Novavax, Inc. (NASDAQ:NVAX) with an Overweight rating and a $18 price target.Novavax (NVAX) Gains M... Full story

Yahoo Finance • 4 months ago

Novavax (NVAX) Jettisons Maryland Facility to AstraZeneca as Investor Pressure Mounts—Is an Acquisition Inevitable?

Earlier this month, Novavax announced it has finalized agreements to transfer its Gaithersburg, Maryland facility and adjoining land to AstraZeneca for nearly US$60 million, while anticipating a significant impairment charge of around US$9... Full story

Yahoo Finance • 4 months ago

Coinbase, eBay upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Citizens JMP upgraded eBay (EBAY) to O... Full story

Yahoo Finance • 4 months ago

Novavax to assign Gaithersburg, Md. facility to AstraZeneca in $60B deal

[relief of handshake] Henrik Sorensen Novavax (NASDAQ:NVAX [https://seekingalpha.com/symbol/NVAX]) on Wednesday announced an agreement to assign its Gaithersburg, Maryland, facility and certain assets to AstraZeneca (NASDAQ:AZN [https://s... Full story

Yahoo Finance • 4 months ago

Novavax shareholder with large stake asks company to consider selling itself

[Germany Begins Novavax Covid Vaccinations] Carsten Koall * Shah Capital Management, which has a 7.2% stake in vaccine maker Novavax (NASDAQ:NVAX [https://seekingalpha.com/symbol/NVAX]), is calling for a strategic review of the company,... Full story

Yahoo Finance • 5 months ago

Next CDC AdCom meeting on vaccines delayed

[Centers for disease control and prevention sign] sshepard The Centers for Disease Control and Prevention (CDC) has postponed an October meeting of its Advisory Committee on Immunization Practices (ACIP), an expert panel whose views are c... Full story

Yahoo Finance • 5 months ago

CDC adopts individual-based decision-making for COVID-19 shots

[Booster shot covid-19 vaccine concept] Wachiwit/iStock via Getty Images The CDC has followed the recommendation [https://seekingalpha.com/news/4496718-cdc-vaccines-panel-votes-unanimously-to-change-covid-19-vaccine-recommendation] of its... Full story